This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
The EURIPID collaboration is currently funded by an annual contribution fee of the participants and – for defined tasks and deliverables – a grant of the EU.
This website is part of the project ’826652 Euripid’ which is co-funded by the European Union’s Health Programme (2014-2020).
The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.
Monitoring the ‘Future of EURIPID’
/in News /by Bettina HeindlThe EURIPID collaboration held its annual meeting of the Board of Participants (BoP) in Brussels on 4-5th June 2024. A total of representatives of 19 BoP members gathered at the Belgian Institute for Health and Disability Insurance (RIZIV INAMI). At the BoP meeting, besides the update on current matters of EURIPID and the presentation of […]
Things you can do with EURIPID data
/in News /by Bettina HeindlThe EURIPID database constitutes more than 30 Mio. data points on prices of medicinal products and since 2019 also information on volumes and the existence of Managed Entry Agreements (MEA) in EURIPID member states. This makes EURIPID a valuable source of information for analyses in the field of pharmaceutical pricing & reimbursement, beyond purposes of […]
Conference Report from the EURIPID Workshop
/in News /by Bettina HeindlOn 25 and 26 April 2024 the 5th PPRI Conference of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies was held at the Palais Niederösterreich in Vienna. More than 250 participants from more than 40 countries discussed about burning challenges related to equitable and affordable access to medicines worldwide (https://ppri.goeg.at/news1). On the second […]